ArticleImmunity, inflammation and disease2026
Atlas-Based Mapping of Traditional Chinese Medicine Effects on Tumor Microcirculation Regulation.
Article in Immunity, inflammation and disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Atlas-Based Mapping of Traditional Chinese Medicine Effects on Tumor Microcirculation Regulation.Immunity, inflammation and disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundTumor microcirculation plays a central role in the onset and progression of hypoxia, therapeutic resistance, and immune evasion within the tumor microenvironment. Traditional Chinese Medicine (TCM), characterized by its multi-targeted and systemic regulatory properties, has garnered increasing attention for its potential to modulate this complex milieu.
methodsWe systematically retrieved core literature published between 2003 and 2025 and conducted a comprehensive bibliometric and knowledge-map analysis of 300 representative publications using CiteSpace and VOSviewer. This approach enabled the identification of key modulatory factors, underlying mechanisms, and evolving research trajectories related to TCM-mediated regulation of tumor microcirculation.
resultsOur findings reveal that TCM formulations and their active constituents-such as Tao Hong Si Wu Decoction, ginsenoside Rg3, and tanshinone IIA-modulate angiogenesis and enhance immune cell infiltration through signaling pathways including VEGF, PI3K/AKT, and HIF-1α. Additionally, non-pharmacological interventions such as acupuncture, electroacupuncture, and moxibustion have been shown to normalize vascular structure, modulate glycolytic activity, and reshape immune polarization. Emerging methodologies such as network pharmacology and molecular docking are increasingly utilized to unravel the complex mechanisms of TCM, facilitating the integration of traditional theories with modern scientific frameworks.
conclusionTCM exhibits a remarkable capacity for multidimensional regulation of tumor microcirculation. Future efforts should focus on rigorous experimental validation and systems-level modeling to accelerate its clinical translation and incorporation into integrative cancer therapy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.